Chronic diabetic wounds may fail to heal because immune cells remain trapped in inflammatory states instead of supporting tissue repair, according to a comprehensive review by researchers examining immune responses in diabetic ulcers and published in MedScience.

More than 131 million people worldwide are affected by chronic diabetic ulcers, which are associated with substantial healthcare costs and serious complications, including amputation and death.

The review examines several immune cell populations, including monocytes, macrophages, neutrophils, dendritic cells, mast cells, B cells, T cells and natural killer cells.

Under normal conditions, immune cells help control infection, remove damaged tissue and coordinate repair. In diabetic wounds, these processes can become disrupted, resulting in persistent inflammation and delayed healing.

Macrophages are particularly important. During normal healing, they transition from pro-inflammatory M1 states towards reparative M2 states. In diabetic wounds, this transition may be impaired, allowing inflammation to continue and damage surrounding tissue.

Dendritic cells may also become less effective at removing dead cells, allowing cellular debris to accumulate and sustain inflammation. Meanwhile, reduced numbers or impaired functioning of regulatory T cells can weaken the body's ability to control inflammation and promote tissue repair. Other immune cells, including mast cells, B cells and natural killer cells, also influence inflammation, immune regulation and the formation of new blood vessels.

The review highlights emerging approaches designed to restore immune balance and improve wound closure. These include anti-inflammatory biologics, treatments targeting macrophage activity, mesenchymal stem cell therapies, extracellular vesicles and advanced wound dressings that deliver therapeutic substances directly to damaged tissue.

Researchers are also investigating treatments that stimulate specific immune cells involved in skin repair. Future treatments could therefore involve personalised approaches based on the immune characteristics of individual wounds. However, further research is needed to establish the safety and effectiveness of these emerging therapies.

REFERENCE: Yi Rue, et al.; Immune cells in diabetic wound repair: the key to better wound management. MedScience, 2025; 19 (6): 950 DOI: 10.1007/s11684-025-1190-y

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .